| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Medicine (D.W.L.) and Department of Biochemistry and Molecular Biology (P.G., D.W.L.), Albany Medical College, Albany, New York 12208
Address all correspondence and requests for reprints to: Dr. Daniel W. Lee, Division of Endocrinology and Metabolism A-44, Albany Medical College, Albany, New York 12208.
In C57BL/6J ob/ob mice, a single base mutation of the ob gene in codon 105 results in the replacement of arginine by a premature stop codon and production of a truncated inactive form of leptin. These observations suggest that leptin activity may be localized, at least in part, to domains distal to amino acid residue 104. To investigate this possibility, we synthesized six overlapping peptide amides corresponding to residues 106167 of leptin, and examined their effects on body weight and food intake in female C57BL/6J ob/ob mice. When compared with vehicle-injected control mice, weight gain by mice receiving 28 daily 1-mg ip injections of LEP-(106120), LEP-(116130), or LEP-(126140) was significantly (P < 0.01) reduced with no apparent toxicity. Weight gain by mice receiving LEP-(136150), LEP-(146160), or LEP-(156167) was not significantly different from that of vehicle-injected control mice. The effects of LEP-(106120), LEP-(116130), or LEP-(126140) were most pronounced during the first week of peptide treatment. Within 7 days, mice receiving these peptides lost 12.3%, 13.8%, and 9.8%, respectively, of their initial body weights. After 28 days, mice given vehicle alone, LEP-(136150), LEP-(146160), or LEP-(156167) were 14.7%, 20.3%, 25.0%, and 24.8% heavier, respectively, than they were at the beginning of the study. Mice given LEP-(106120) or LEP-(126140) were only 1.8% and 4.2% heavier, respectively, whereas mice given LEP-(116130) were 3.4% lighter. Food intake by mice receiving LEP-(106120), LEP-(116130), or LEP-(126140), but not by mice receiving LEP-(136150), LEP-(146160), or LEP-(156167), was reduced by 15%. The results of this study indicate 1) that leptin activity is localized, at least in part, in domains between residues 106140; 2) that leptin-related peptides have in vivo effects similar to those of native leptin; and 3) offer hope for development of peptide analogs of leptin having potential application in human or veterinary medicine.
This article has been cited by other articles:
![]() |
M. Rozhavskaya-Arena, D. W. Lee, M. C. Leinung, and P. Grasso Design of a Synthetic Leptin Agonist: Effects on Energy Balance, Glucose Homeostasis, and Thermoregulation Endocrinology, July 1, 2000; 141(7): 2501 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rau, B. J. Reaves, S. ORahilly, and J. P. Whitehead Truncated Human Leptin ({Delta}133) Associated with Extreme Obesity Undergoes Proteasomal Degradation after Defective Intracellular Transport Endocrinology, April 1, 1999; 140(4): 1718 - 1723. [Abstract] [Full Text] |
||||
![]() |
K. Imagawa, Y. Numata, G. Katsuura, I. Sakaguchi, A. Morita, S. Kikuoka, Y. Matumoto, T. Tsuji, M. Tamaki, K. Sasakura, et al. Structure-Function Studies of Human Leptin J. Biol. Chem., December 25, 1998; 273(52): 35245 - 35249. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |